Results 231 to 240 of about 20,692 (311)
Prolonged symptoms of otitis media (OM) are common among patients with severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). There are multiple biologics available for difficult‐to‐treat asthma and CRSwNP. However, few studies describe the effect of biologics on associated OM.
Anna Suikkila+4 more
wiley +1 more source
Four Cases of Prurigo Nodularis Requiring Nemolizumab due to Persistent Pruritus or Lesions after Dupilumab Treatment. [PDF]
Mima Y, Yamamoto M, Iozumi K.
europepmc +1 more source
ABSTRACT This open‐label, single‐arm, multicenter clinical study evaluated the treatment satisfaction, efficacy, and safety of 0.5% delgocitinib ointment twice daily for 12 weeks, applied to face/neck lesions caused by ≥ 3 months use of topical steroids or tacrolimus ointment in patients with atopic dermatitis (AD).
Masatoshi Abe+5 more
wiley +1 more source
Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 Asthma. [PDF]
Bacharier LB+7 more
europepmc +1 more source
S2513 Giant Cell Hepatitis Due to Drug-Induced Autoimmune Hepatitis from Dupilumab
Scott R. Douglas+3 more
openalex +1 more source
Analyzing the Efficacy of Dupilumab on Skin Clearance in Pediatric Patients with Atopic Dermatitis
Severe atopic dermatitis significantly impairs the quality of life for infants and young children, along with their family members and caregivers. Atopic dermatitis is a chronic inflammatory disease of the skin.
Procopoi, Naomy
core
Contact Urticaria and Related Conditions: Clinical Review
ABSTRACT Contact urticaria (CoU) is an immediate contact reaction occurring within minutes to an hour after exposure to specific proteins or chemicals. CoU is categorised into non‐immunologic (NI‐CoU) and immunologic (I‐CoU) types, with I‐CoU potentially leading to anaphylaxis. Both forms of CoU can be associated with protein contact dermatitis and the
Mojca Bizjak+15 more
wiley +1 more source
Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation. [PDF]
Takamura S, Fukuda T.
europepmc +1 more source
French guidelines for the management of atopic dermatitis
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Nina Sigg+16 more
wiley +1 more source